Tombozine is primarily used in research settings for its potential neuroprotective properties. It has shown interest in studies related to cognitive function and memory enhancement, particularly in models of neurodegenerative diseases such as Alzheimer's. The compound interacts with specific neuronal receptors involved in synaptic plasticity, making it a candidate for exploring new pathways in brain health. Additionally, Tombozine has been investigated for its anti-inflammatory effects within the central nervous system, which may contribute to its observed neuroprotective activity. Due to its ability to cross the blood-brain barrier efficiently, it is considered a valuable tool in preclinical studies aiming to develop treatments for neurological disorders.